Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease
Author(s) -
Michael C. Honigberg,
Lee-Shing Chang,
Darren K. McGuire,
Jorge Plutzky,
Vanita R. Aroda,
Muthiah Vaduganathan
Publication year - 2020
Publication title -
jama cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.108
H-Index - 63
eISSN - 2380-6591
pISSN - 2380-6583
DOI - 10.1001/jamacardio.2020.1966
Subject(s) - medicine , semaglutide , liraglutide , dulaglutide , type 2 diabetes , diabetes mellitus , hypoglycemia , exenatide , glycemic , intensive care medicine , adverse effect , clinical trial , insulin , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom